Drug Type AAV based gene therapy |
Synonyms- |
Target |
Mechanism Kv1.1 modulators(Voltage-gated potassium channel subunit Kv1.1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Preclinical | GB | 17 Apr 2019 |